NPR

Five Coronavirus Treatments In Development

While only remdesivir has been scientifically shown to help treat COVID-19, it is not a particularly effective drug. More drugs like it and fundamentally different ones are in the pipeline.
A researcher at the German Center for Immunity Therapy holds a bag containing blood plasma from a recovered COVID-19 patient at the University Hospital Erlangen on April 27, 2020 in Erlangen, Germany. This plasma could be used to treat people with COVID-19.

Right now, there is only one drug shown by rigorous scientific testing to be helpful for treating COVID-19. That drug is the antiviral medication called remdesivir, made by Gilead Sciences. But remdesivir's proven benefits are modest: reducing hospital stays from 15 to 11 days.

So there's an urgent need for better therapies. The good news is that there are some on the horizon. Some are being tested now, some will be begin testing soon, and others are in the beginning of the pipeline.

Convalescent plasma

You’re reading a preview, subscribe to read more.

More from NPR

NPR4 min readSocial History
What Abortion Politics Has To Do With New Rights For Pregnant Workers
A new regulation to protect the rights of pregnant workers is the subject of an anti-abortion lawsuit because it includes abortion as a pregnancy "related medical condition."
NPR2 min read
The Louvre Museum Looks To Rehouse The 'Mona Lisa' In Its Own Room — Underground
Louvre Director Laurence des Cars said her institution is looking at upgrading both the visitor experience surrounding the iconic painting as well as the museum overall.
NPR2 min read
Candace Parker, 3-time WNBA And 2-time Olympic Champion, Says 'It's Time' To Retire
After 16 seasons, two Olympic gold medals and three WNBA championships, Candace Parker announced her retirement from professional basketball on Sunday.

Related Books & Audiobooks